2013 2012 2011 2010 2009 2008‒2001 2000及以前 专利
论文和专著
--- 2013 ---
1. W. Guo, W. Zheng, Q. Luo, X. Li, Y. Zhao, S. Xiong and F.-Y. Wang*, Transferrin Serves As a Mediator to Deliver Organometallic Ruthenium(II) Anticancer Complexes into Cells, Inorg. Chem., 2013, 52, 5328-5338.
2. G.-B. Ge, C.-Z. Ai, W.-B. Hu, J. Hou, L.-L. Zhu, G.-Y. He, Z.-Z. Fang, S.-C. Liang, F.-Y. Wang*, L. Yang*, The role of serum albumin in the metabolism of Boc5: molecular identification, species differences and contribution to plasma metabolism, Eur. J. Pharm. Sci., 2013, 48, 360-369.
3. K. Wu, W. Hu, Q. Luo, X. Li, S. Xiong, P. Sadler, F.-Y. Wang*, Competitive binding sites of a ruthenium arene anticancer complex on oligonucleotides studied by mass spectrometry: ladder-sequencing vs top-down, J. Am. Soc. Mass. Spectrom., 2013, 24, 410-420.
4. F.-Y. Wang, J. Xu, K. Wu, S. K. Weidt, C. L. Mackay, P. R. R. Langridge-Smith, P. J. Sadler*, Competition between glutathione and DNA oligonucleotides for ruthenium(II) arene anticancer complexes, Dalton Trans. 2013, 42, 3188-3195.
5. S. Lü, W. Zheng, L. Ji, Q. Luo, X. Hao, X. Li, F.-Y. Wang*, Synthesis, characterization, screening and docking analysis of 4-anilinoquinazoline derivatives as tyrosine kinase inhibitors, Eur. J. Med. Chem. 2013, 61, 84-94.
--- 2012 ---
6. X. Li, Z. Zhao, W. Hu, F.-Y. Wang,* Interactions between cisplatin and proteins, and their pharmacological implications in Cisplatin: Pharmacology, Clinical Uses and Adverse Effects, Eds: Toshiko Kojima and Yoko Moria, pp75-95, Nove Science Publishers, Inc, U.S.A., 2012.
7. Y. Jin, Y. Huang*, Y. Xie, W. Hu, F.-Y. Wang, G. Liu, R. Zhao*, Cyclic interconversion of methionine containing peptide between oxidized and reduced phases monitored by reversed-phase HPLC and ESI-MS/MS, Talanta 2012, 89, 531-536.
8. L. Ji, J.-H. Wu, Q. Luo, X. Li, W. Zheng, G. Zhai, F.-Y. Wang*, S. Lü, Y.-Q. Feng*, J. Liu, S. Xiong, Quantitative Mass Spectrometry Combined with Separation and Enrichment of Phosphopeptides by Titania Coated Magnetic Mesoporous Silica Microspheres for Screening of Protein Kinase Inhibitors, Anal. Chem. 2012, 84, 2284-2291.
9. K. Wu, Q. Luo, W. Hu, X. Li, F.-Y. Wang*, S. Xiong, P. J. Sadler*, Mechanism of Interstrand Migration of Organoruthenium Anticancer Complexes within a DNA Duplex, Metallomics, 2012, 4, 136-148
--- 2011---
10. S. Lü, Q. Luo, X. Hao, X. Li, L. Ji, W. Zheng, F.-Y. Wang*, Synthesis and docking study of 2-phenylaminopyrimidine Abl tyrosine kinase inhibitors, Bioorg. Med. Chem. Lett. 2011, 21, 6964-6968.
11. Y. Han, Q. Luo, X. Hao, X. Li, F.-Y. Wang*, W. Hu, K. Wu, S. Lu, P. J. Sadler*, Reactions of an organoruthenium anticancer complex with 2-mercaptobenzanilide - a model for the active-site cysteine of protein tyrosine phosphatase 1B, Dalton Trans. 2011, 40, 11519-11529.
12. W. Hu, Q. Luo, K. Wu, X. Li, F.-Y Wang*, Y. Chen, X. Ma, J. Wang, J. Liu, S. Xiong, P. J. Sadler*, The anticancer drug cisplatin can cross-link the interdomain zinc site on human albumin, Chem. Commun. 2011, 47, 6006-6008.
13. W. Hu, J. Liu, Q. Luo*, Y. Han, K. Wu, S. Lv, S. Xiong, F.-Y. Wang,* Elucidation of the Binding Sites of Sodium Dodecyl Sulfate to b-Lactoglobulin Using Hydrogen/Deuterium Exchange Mass Spectrometry Combined with Docking Simulation, Rapid Commun. Mass Spectrom. 2011, 25, 1429-1436.
14. G. Zhang, W. Hu, Z. Du, S. Lv, W. Zheng, Q. Luo, X. Li, K. Wu, Y. Han, F.-Y. Wang*, A Comparative Study on Interactions of Cisplatin and Ruthenium Arene Anticancer Complexes with Metallothionein using MALDI-TOF-MS, Intl. J. Mass Spectrom. 2011, 307, 79-84
15. C. Yao, L. Qi*, W. Hu, F.-Y Wang, G. Yang, Immobilization of trypsin on sub-micron skeletal polymer monolith, Ana. Chim. Acta, 2011, 692, 131-137.
16. Q. Luo, D. Wu, S. Liu, D. Tang*, Y. Huang, X. Liu, F.-Y. Wang*, R. Wang, G. Wu*, The formation of thymidine-based t-tetramers with remarkable structural and metal ion size effects, Org. Biomol. Chem., 2011, 9,1030-1033
--- 2010 ---
17. S. Lv, Q. Luo, X. Li, K. Wu, J. Liu, S. X. Xiong, Y. Feng, F.-Y. Wang*, Inhibitor Screening of Protein Kinases Using MALDI-TOF MS Combined with Separation and Enrichment of Phosphopeptides by TiO2 Nanoparticle Deposited Capillary Column, Analyst, 2010, 135, 2858-2863.
18. X. Wei, L. Qi*, J. Qiao, C. Yao, F.-Y. Wang, Y. Chen, Assay of vitamin B in urine by capillary electrochromatography with methacrylate-based monolithic column, Electrophoresis, 2010, 31(19), 3227-3232.
19. C. Yao, L. Qi*, J. Qiao, H. Zhang, F.-Y. Wang, G. Yang, Y. Chen, High-performance affinity monolith chromatography for enantiomer separation and determination of enzyme kinetic constant, Talanta, 2010, 82(4), 1332-1337.
20. X. Wei, L. Qi*, J. Tan, R. Liu, F.-Y. Wang, A colorimetric sensor for determination of cysteine by carboxymethyl cellulose functionalized gold nanoparticle, Anal. Chim. Acta, 2010, 671, 80-84.
21. C. Yao, L. Qi*, G. Yang, F.-Y. Wang, Preparation of sub-micron skeletal monolith with high capacity for liquid chromatography, J. Sep. Sci., 2010, 33, 475-483.
22. H. Liu*, J. A. Parkinson, J. Bella, F.-Y. Wang, P. J. Sadler*, Penetrative DNA intercalation and G-base selectivity of an organometallic tetrahydroanthracene RuII anticancer complex, Chem. Sci., 2010, 1, 258-270.
23. 胡文兵，汪福意*，质谱在金属抗肿瘤药物与蛋白质相互作用研究中的应用（邀请综述），质谱学报，2010，31，354-361.
--- 2009 ---
24. X. Wei, L. Qi, G. Yang, F.-Y. Wang*, Preparation and characterization of monolithic column by grating pH-responsive polymer, Talanta, 2009, 79, 739-745
25. D. Tang*, D. Wu, Q. Luo, W. Hu, F.-Y. Wang*, S. Liu, X. Liu, Q. Fan, Single-molecule behavior of dendritic poly(ethylene glycol) structures towards lithium ions, Chem. Eur. J. 2009, 15, 10352-10355.
26. Y. Wang, F. Li, Y. Han, F.-Y. Wang, H. Jiang*, Folding and aggregation of cationic oligo(aryl-triazole)s in aqueous solution, Chem. Eur. J., 2009, 15, 9424-9433.
27. W. Hu, Q. Luo, X. Ma, K. Wu, J. Liu, Y. Chen, S. Xiong, J. Wang*, P. J. Sadler*, F.-Y. Wang,* Arene control over thiolate to sulfinate oxidation in albumin by organometallic ruthenium anticancer complexes, Chem. Eur. J. 2009, 15, 6586-6594.
28. F.-Y. Wang*, A. Habtemariam, E. P. L. van der Geer, R. J. Deeth, R. Gould, S. Parsons, P. J. Sadler,* Synthesis, characterization and reaction pathway for the formation of a GMP adduct of a cytotoxic thiocyanato ruthenium arene complex, J. Biol. Inorg. Chem., 2009, 14, 1065-1076.
29. F.-Y. Wang*, W.B. Hu, Q. Luo, X.Y. Ma, J.P. Wang, P.J. Sadler*, Arene-controlled binding of organoruthenium anticancer complexes to albumin and Ru-induced oxidation of Cys34 Thiol, J. Biol. Inorg. Chem. 2009, 14(Supp1), S235.
--- 2008 ‒ 2001 ---
30. F.-Y. Wang, S. Weidt, J. Xu, C. L. Mackay, P. R. R. Langridge-Smith, P. J. Sadler, Identification of clusters from reactions of ruthenium arene anticancer complex with glutathione using nanoscale liquid chromatography Fourier transform ion cyclotron mass spectrometry combined with 18O-labelling, J. Am. Soc. Mass Spectrom. 2008, 19, 544-549
31. H. K. Liu, S. J. Berners-Price, F.-Y. Wang, J. A. Parkinson, J. Xu, J. Bella, P. J. Sadler*, Diversity in G-selective DNA binding modes for an organometallic ruthenium arene complex, Angew. Chem. Int. Ed. 2006, 45, 8153-8156
32. H. K. Liu, F.-Y. Wang, J. A. Parkinson, J. Bella, P. J. Sadler*, Ruthenation of duplex and single-stranded d(CGGCCG) by organometallic anticancer complexes, Chem. Eur. J. 2006, 12, 6151-6165
33. F.-Y. Wang, A. Habtemariam, E. P. L. van der Geer, R. Fernández, M. Melchart, R. J. Deeth, R. Aird, S. Guichard, F. P. A. Fabbiani, P. Lozano-Casal, I. D. H. Oswald, D. I. Jodrell, S. Parsons, P. J. Sadler, Controlling ligand substitution reactions of organometallic complexes: tuning cancer cell cytotoxicity, Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 18269-18274.
34. F.-Y. Wang, J. Xu, A. Habtemariam, J. Bella, P. J. Sadler*, Competition between glutathione and guanine for a ruthenium(II) arene anticancer complex: detection of a sulfenato intermediate. J. Am. Chem. Soc. 2005, 127, 17734-17743.
35. F.-Y. Wang, J. Bella, J. A. Parkinson, P. J. Sadler*, Competitive reactions of a ruthenium arene anticancer complex with histidine, cytochrome c and an oligonucleotide. J. Biol. Inorg. Chem. 2005, 10, 147-55.
36. I. W. McNae, K. Fishburne, A. Habtemariam, T. M. Hunter, M. Melchart, F.-Y. Wang, M. D. Walkinshaw, P. J. Sadler*, Half-sandwich arene ruthenium(II)-enzyme complex. Chem. Commun. 2004, 1786-1787.
37. F.-Y Wang, H. M. Chen, S. Parsons, I. D. H. Oswald, J. E. Davidson, P. J. Sadler*, Kinetics of aquation and anation of ruthenium(II) arene anticancer complexes, acidity and X-ray structures of aqua adducts. Chem. Eur. J. 2003, 9, 5810-5820.
38. R. Fernandez, M. Melchart, E. Van Der Geer, F.-Y. Wang, A. Habtemariam, P. J. Sadler*, Ruthenium(II) arene anticancer complexes: Selective recognition of nucleobases and control of hydrolysis rates. J. Inorg. Biochem. 2003, 96, 130-130.
39. H. M. Chen, J. A. Parkinson, O. Novakova, J. Bella, F. Y. Wang, A. Dawson, R. Gould, S. Parsons, V. Brabec, P. J. Sadler*, Induced-fit recognition of DNA by organometallic complexes with dynamic stereogenic centers. Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 14623-14628.
40. F. Y. Wang, B. Hu, Z. C. Jiang, Y. L. Wu, Study on the chemical modification of acetylacetone in graphite furnace atomic absorption spectrometry determination of trace aluminium. Anal. Lett. 2002, 35, 2593-2602.
41. F. Y. Wang, H. M. Chen, J. A. Parkinson, P. D. Murdoch, P. J. Sadler*, Reactions of a ruthenium(II) arene antitumor complex with cysteine and methionine. Inorg. Chem. 2002, 41, 4509-4523.
--- 2000及以前 ---
42. H. Z. Liu, F. Y. Wang, Z. C. Jiang, Study on adsorption properties of cinchonine loaded resin to Mo and V by ICP-AES. Anal. Lett. 2000, 33, 2021-2029.
43. F. Y. Wang, Z. C. Jiang, T. Y. Peng, Use of polytetrafluoroethylene slurry for silica matrix removal in ETAAS direct determination of trace cobalt and nickel in silicon dioxide powder. J. Anal. At. Spectrom. 1999, 14, 963-966.
44. F. Y. Wang, Z. C. Jiang, B. Hu,T. Y. Peng, Comparative studies on chemical modification of polytetrafluoroethylene slurry in ETV-ICP-AES and ETAAS. J. Anal. At. Spectrom. 1999, 14, 1619-1624.
45. F. Y. Wang, Z. C. Jiang, Direct determination of cadmium in solid biological materials by slurry sampling electrothermal atomic absorption spectrometry with polytetrafluoroethylene as a chemical modifier. Anal. Chim. Acta 1999, 391, 89-94.
46. 汪福意, 江祖成，电热原子吸收光谱直接分析固体样品（综述），分析科学学报，2001, 17, 245
47. 汪福意，江祖成，聚四氟乙烯修饰悬浮体进样电热原子吸收光谱直接分析固体样品中的金属铬，分析科学学报，1999, 15, 111-114.
48. F.-Y. Wang, Z. C. Jiang, study of the determination of trace amounts of chromium by electrothermal atomic absorption spectrometry with a poly(tetrafluoroethylene) slurry as a chemical modifier. J. Anal. At. Spectrom. 1998, 13, 539-542.
专利
1. 汪福意，韩玉苗，罗群，郑伟，吴魁，李鲜婵，抑制蛋白酪氨酸磷酸酶1B活性的含钌配合物及其制备方法和蛋白酪氨酸磷酸酶1B抑制剂，中国发明专利申请号：201210103485.8
2. 汪福意，罗群，纪丽云，郑伟，吕爽，李鲜婵，一种抑制肿瘤细胞增殖的喹唑啉衍生物/喹唑啉配合物蛋白激酶抑制剂及它们的制备方法，PCT发明专利申请号：PCT/CN2011/081453
3. 汪福意，罗群，纪丽云，郑伟，吕爽，一种喹唑啉衍生物蛋白激酶抑制剂，中国发明专利申请号：201010521382.4
4. 汪福意，罗群，吕爽，纪丽云，胡文兵，吴魁，韩玉苗，一种酪氨酸蛋白激酶抑制剂及其制备方法，中国发明专利公开号：CN101890018A
5. 汪福意，罗群，吕爽，吴魁，胡文兵，纪丽云，韩玉苗，有机金属钌抗肿瘤化合物，中国发明专利公开号：CN101891627A
